• 2024 Policy Preview: An Interview with Dr. Mark McClellan

  • Jan 30 2024
  • Duración: 50 m
  • Podcast

2024 Policy Preview: An Interview with Dr. Mark McClellan Por arte de portada

2024 Policy Preview: An Interview with Dr. Mark McClellan

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Scott and Mark welcome Dr. Mark McClellan, a distinguished health policy expert who has served as the Commissioner of the FDA and the Administrator of CMS, to look ahead at the major policy activities in 2024. They discuss how the government's role as regulator and purchaser of drugs will influence the drug industry and the patient's ability to access and afford medicines this year. They also discuss the challenges and opportunities for improving public health and the emerging role of artificial intelligence.

    Dr. Mark McClellan, PhD, Director and Professor of Business, Medicine and Policy at the Duke-Margolis Center for Health Policy at Duke University

    IRA

    Medicare Part D

    Pharmacy Benefit Managers (PBMs)

    Medicare Advantage

    FDA commissioner Rob Califf

    The Ryan White HIV/AIDS Program (RWHAP) Part B

    Medicare Modernization Act

    FDA

    FDA's Office of Regulatory Affairs

    Centers for Medicare & Medicaid Services (CMS)

    Centers for Disease Control and Prevention (CDC)

    Per Member Per Month (PMPM) billing

    Questions or comments?
    Email us at comments@prescriptionforbetteraccess.com.
    Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
    Más Menos
activate_primeday_promo_in_buybox_DT
Enfermedades Físicas Hygiene & Healthy Living Ciencias Biológicas
Más Menos

Lo que los oyentes dicen sobre 2024 Policy Preview: An Interview with Dr. Mark McClellan

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles